US FDA approves Vera's kidney disease drug
By Siddhi Mahatole July 7 (Reuters) - The U.S. Food and Drug Administration has approved Vera Therapeutics' drug to treat ...
STAT
Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and more
We’re here in STAT’s Brooklyn outpost today, where everyone’s gazing across the East River to see whether Pfizer’s former ...
Asianet Newsable on MSN
VERA stock surges after drug to treat rare kidney disease gets FDA approval – retail sees the move as catalyst for Vera Therapeutics
Vera Therapeutics' Trutakna received an early, fast-tracked approval from the FDA to reduce proteinuria in adults with primary IgA Nephropathy whose health is at risk of deterioration.
The Silicon Review
FDA Approves Vera's Trutakna: First Dual-Target IgAN Therapy Sets Up Market Showdown with Novartis and Otsuka
FDA grants accelerated approval to Vera's Trutakna for IgA nephropathy, first dual BAFF/APRIL inhibitor. Competes with ...
Vera Therapeutics wins FDA nod for closely watched kidney disease drug
The clearance marks another step forward in treatment for IgA nephropathy and sets up a commercial battle with Otsuka, which ...
FDA grants accelerated approval to Vera Therapeutics' Trutakna
Trutakna, priced at $425,000 per year, is the first drug approved in the U.S. that targets both BAFF and APRIL proteins ...
STAT
FDA approves Vera Therapeutics kidney disease treatment
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
Vera Therapeutics Gets FDA Accelerated Approval for Trutakna in IgA Kidney Disease
Vera Therapeutics said the U.S. Food and Drug Administration granted accelerated approval for Trutakna to reduce proteinuria, or protein in urine, for adults with primary IgA nephropathy who are at ...
Under the Radar: Vera Stock Jumps as Kidney-Disease Drug Approved by FDA
Shares of Vera Therapeutics rose about 8% Tuesday after the Food and Drug Administration approved its treatment for a kidney disease, IgA nephropathy, that affects about 160,000 people in the U.S. and ...
Daily Graphic
US FDA approves kidney disease drug
The US FDA has approved Trutakna, a first-in-class treatment for IgA nephropathy developed by Vera Therapeutics, offering new ...
FiercePharma
FDA approves Vera’s dual-target Trutakna, setting up IgAN market battle with Novartis, Otsuka
When Vera Therapeutics in-licensed atacicept from Merck KGaA about six years ago, patients with IgA nephropathy (IgAN) had no FDA-approved treatment options. Today, the dual-target drug has crossed ...
Reuters
US FDA approves Vera's kidney disease drug
July 7 (Reuters) - The U.S. Food and Drug Administration said on Tuesday it had approved Vera Therapeutics' (VERA.O), opens new tab drug to treat patients with a potentially life-threatening kidney ...